October 15, 2019 / 11:04 AM / a month ago

BRIEF-CRISPR Therapeutics And KSQ Therapeutics Announce License Agreement To Advance Companies' Respective Cell Therapy Programs In Oncology

Oct 15 (Reuters) - CRISPR Therapeutics AG:

* CRISPR THERAPEUTICS AND KSQ THERAPEUTICS ANNOUNCE LICENSE AGREEMENT TO ADVANCE COMPANIES’ RESPECTIVE CELL THERAPY PROGRAMS IN ONCOLOGY

* CRISPR THERAPEUTICS AG - KSQ THERAPEUTICS TO RECEIVE NON-EXCLUSIVE ACCESS TO CERTAIN CRISPR IP FOR ITS AUTOLOGOUS CELL THERAPIES

* CRISPR THERAPEUTICS AG - TO RECEIVE NON-EXCLUSIVE ACCESS TO CERTAIN KSQ IP FOR ITS ALLOGENEIC CAR-T PROGRAMS

* CRISPR THERAPEUTICS AG - FINANCIAL TERMS OF AGREEMENT ARE NOT BEING DISCLOSED. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below